Global Intravenous Iron Drugs Market Research Report 2023(Status and Outlook)

Global Intravenous Iron Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.

Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.

The Global Intravenous Iron Drugs Market Size was estimated at USD 1449.20 million in 2022 and is projected to reach USD 1919.92 million by 2029, exhibiting a CAGR of 4.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Intravenous Iron Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Iron Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Iron Drugs market in any manner.

Global Intravenous Iron Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Allergan

AMAG Pharmaceuticals

Daiichi Sankyo

Galenica

Pharmacosmos

Nippon Shinyaku

NOXXON Pharma

Rockwell Medical

Sanofi

Wanbang Biopharmaceutical

Market Segmentation (by Type)

Ferric Gluconate

Ferric Carboxymaltose

Iron Sucrose

Iron Dextran

Market Segmentation (by Application)

Cement

Power

Steel

Aluminum

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Intravenous Iron Drugs Market

Overview of the regional outlook of the Intravenous Iron Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Intravenous Iron Drugs
1.2 Key Market Segments
1.2.1 Intravenous Iron Drugs Segment by Type
1.2.2 Intravenous Iron Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Intravenous Iron Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Intravenous Iron Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Intravenous Iron Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Intravenous Iron Drugs Market Competitive Landscape
3.1 Global Intravenous Iron Drugs Sales by Manufacturers (2018-2023)
3.2 Global Intravenous Iron Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intravenous Iron Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Intravenous Iron Drugs Sales Sites, Area Served, Product Type
3.6 Intravenous Iron Drugs Market Competitive Situation and Trends
3.6.1 Intravenous Iron Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Intravenous Iron Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Intravenous Iron Drugs Industry Chain Analysis
4.1 Intravenous Iron Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Intravenous Iron Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Intravenous Iron Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intravenous Iron Drugs Sales Market Share by Type (2018-2023)
6.3 Global Intravenous Iron Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Intravenous Iron Drugs Price by Type (2018-2023)
7 Intravenous Iron Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intravenous Iron Drugs Market Sales by Application (2018-2023)
7.3 Global Intravenous Iron Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Intravenous Iron Drugs Sales Growth Rate by Application (2018-2023)
8 Intravenous Iron Drugs Market Segmentation by Region
8.1 Global Intravenous Iron Drugs Sales by Region
8.1.1 Global Intravenous Iron Drugs Sales by Region
8.1.2 Global Intravenous Iron Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Intravenous Iron Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Intravenous Iron Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Intravenous Iron Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Intravenous Iron Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Intravenous Iron Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Intravenous Iron Drugs Basic Information
9.1.2 Allergan Intravenous Iron Drugs Product Overview
9.1.3 Allergan Intravenous Iron Drugs Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Intravenous Iron Drugs SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 AMAG Pharmaceuticals
9.2.1 AMAG Pharmaceuticals Intravenous Iron Drugs Basic Information
9.2.2 AMAG Pharmaceuticals Intravenous Iron Drugs Product Overview
9.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Product Market Performance
9.2.4 AMAG Pharmaceuticals Business Overview
9.2.5 AMAG Pharmaceuticals Intravenous Iron Drugs SWOT Analysis
9.2.6 AMAG Pharmaceuticals Recent Developments
9.3 Daiichi Sankyo
9.3.1 Daiichi Sankyo Intravenous Iron Drugs Basic Information
9.3.2 Daiichi Sankyo Intravenous Iron Drugs Product Overview
9.3.3 Daiichi Sankyo Intravenous Iron Drugs Product Market Performance
9.3.4 Daiichi Sankyo Business Overview
9.3.5 Daiichi Sankyo Intravenous Iron Drugs SWOT Analysis
9.3.6 Daiichi Sankyo Recent Developments
9.4 Galenica
9.4.1 Galenica Intravenous Iron Drugs Basic Information
9.4.2 Galenica Intravenous Iron Drugs Product Overview
9.4.3 Galenica Intravenous Iron Drugs Product Market Performance
9.4.4 Galenica Business Overview
9.4.5 Galenica Intravenous Iron Drugs SWOT Analysis
9.4.6 Galenica Recent Developments
9.5 Pharmacosmos
9.5.1 Pharmacosmos Intravenous Iron Drugs Basic Information
9.5.2 Pharmacosmos Intravenous Iron Drugs Product Overview
9.5.3 Pharmacosmos Intravenous Iron Drugs Product Market Performance
9.5.4 Pharmacosmos Business Overview
9.5.5 Pharmacosmos Intravenous Iron Drugs SWOT Analysis
9.5.6 Pharmacosmos Recent Developments
9.6 Nippon Shinyaku
9.6.1 Nippon Shinyaku Intravenous Iron Drugs Basic Information
9.6.2 Nippon Shinyaku Intravenous Iron Drugs Product Overview
9.6.3 Nippon Shinyaku Intravenous Iron Drugs Product Market Performance
9.6.4 Nippon Shinyaku Business Overview
9.6.5 Nippon Shinyaku Recent Developments
9.7 NOXXON Pharma
9.7.1 NOXXON Pharma Intravenous Iron Drugs Basic Information
9.7.2 NOXXON Pharma Intravenous Iron Drugs Product Overview
9.7.3 NOXXON Pharma Intravenous Iron Drugs Product Market Performance
9.7.4 NOXXON Pharma Business Overview
9.7.5 NOXXON Pharma Recent Developments
9.8 Rockwell Medical
9.8.1 Rockwell Medical Intravenous Iron Drugs Basic Information
9.8.2 Rockwell Medical Intravenous Iron Drugs Product Overview
9.8.3 Rockwell Medical Intravenous Iron Drugs Product Market Performance
9.8.4 Rockwell Medical Business Overview
9.8.5 Rockwell Medical Recent Developments
9.9 Sanofi
9.9.1 Sanofi Intravenous Iron Drugs Basic Information
9.9.2 Sanofi Intravenous Iron Drugs Product Overview
9.9.3 Sanofi Intravenous Iron Drugs Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
9.10 Wanbang Biopharmaceutical
9.10.1 Wanbang Biopharmaceutical Intravenous Iron Drugs Basic Information
9.10.2 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Overview
9.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Market Performance
9.10.4 Wanbang Biopharmaceutical Business Overview
9.10.5 Wanbang Biopharmaceutical Recent Developments
10 Intravenous Iron Drugs Market Forecast by Region
10.1 Global Intravenous Iron Drugs Market Size Forecast
10.2 Global Intravenous Iron Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Intravenous Iron Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Intravenous Iron Drugs Market Size Forecast by Region
10.2.4 South America Intravenous Iron Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Intravenous Iron Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Intravenous Iron Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Intravenous Iron Drugs by Type (2024-2029)
11.1.2 Global Intravenous Iron Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Intravenous Iron Drugs by Type (2024-2029)
11.2 Global Intravenous Iron Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Intravenous Iron Drugs Sales (K MT) Forecast by Application
11.2.2 Global Intravenous Iron Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings